It is well known that maintaining a healthy weight, limiting alcohol consumption, and taking precautions against sun exposure can reduce the risk of developing certain cancers and improve treatment outcomes in patients diagnosed with specific cancers.
After two recent clinical trials provided long-awaited new information on the role of lymph node management in patients with melanoma, a panel was formed to update the 2012 ASCO-Society of Surgical Oncology (SSO) guidelines for sentinel lymph node (SLN) biopsy.
Data presented during the 2012 ASCO Annual Meeting demonstrated the potential of anti–PD-1 and anti–PD-L1 therapy for multiple cancers and introduced groundbreaking change in oncology research and treatment.
Enrique Soto, MD, of the Salvador Zubiran National Institute of Medical Science and Nutrition, in Mexico City, grew up to the sound of seismic alarms. Mexico City is located on a fault line, and Dr. Soto was no stranger to feeling the earth shake beneath his feet.
Lori J. Pierce, MD, FASCO, a professor of radiation oncology at the University of Michigan School of Medicine and the University’s Vice Provost for Academic and Faculty Affairs, is this year’s recipient of the Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award.
With more than 35,000 oncology professionals from around the world gathering to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field, the ASCO Annual Meeting is an unparalleled opportunity for attendees to advance their work through networking.